US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 0.546
- +0.009+1.75%
Trading Aug 19 10:10 ET
9.03MMarket Cap-142P/E (TTM)
0.546High0.501Low11.10KVolume0.538Open0.537Pre Close5.77KTurnover0.10%Turnover RatioLossP/E (Static)16.52MShares14.55052wk High-0.82P/B5.90MFloat Cap0.26752wk Low--Dividend TTM10.79MShs Float14.550Historical High--Div YieldTTM8.48%Amplitude0.267Historical Low0.519Avg Price1Lot Size
Psyence Biomedical Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q2)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q2)Sep 30, 2022 | (FY)Mar 31, 2022 | |
|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expense | 1,267.39%44.23M | -28.75%173.85K | 74.30%3.23M | 244K | 1.86M |
| Selling and administrative expenses | 10.52%1.8M | -18.16%198.18K | -5.40%1.63M | --242.15K | --1.72M |
| -Selling and marketing expense | 1,046.72%80.6K | --1.08K | -59.86%7.03K | --0 | --17.51K |
| -General and administrative expense | 6.02%1.72M | -18.60%197.1K | -4.84%1.62M | --242.15K | --1.7M |
| Research and development costs | -40.67%954.59K | ---- | 1,072.35%1.61M | --1.85K | --137.24K |
| Depreciation amortization depletion | --240 | ---- | --0 | ---- | ---- |
| -Depreciation and amortization | --240 | ---- | --0 | ---- | ---- |
| Other operating expenses | --41.48M | ---24.34K | ---- | ---- | ---- |
| Operating profit | -1,267.39%-44.23M | 28.75%-173.85K | -74.30%-3.23M | -244K | -1.86M |
| Net non-operating interest income expense | -3,369.43%-50.81K | -3,558.92%-27.57K | 1.55K | 797.0283 | 0 |
| Non-operating interest income | 37.32%2.13K | ---- | --1.55K | ---- | --0 |
| Non-operating interest expense | --52.94K | ---- | --0 | ---- | ---- |
| Total other finance cost | ---- | 3,558.92%27.57K | ---- | ---797.0283 | ---- |
| Other net income (expense) | -25,645.52%-6.87M | -7,006.67%-104.19K | 1,276.42%26.91K | -1.47K | -2.29K |
| Gain on sale of security | -1,247.98%-308.95K | -7,006.67%-104.19K | 1,276.42%26.91K | ---1.47K | ---2.29K |
| Special income (charges) | ---2.18M | ---- | --0 | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --2.46M | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---281.5K | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---4.39M | ---- | ---- | ---- | ---- |
| Income before tax | -1,495.53%-51.16M | -24.91%-305.6K | -72.55%-3.21M | -244.67K | -1.86M |
| Income tax | |||||
| Net income | -1,495.53%-51.16M | -24.91%-305.6K | -72.55%-3.21M | -244.67K | -1.86M |
| Net income continuous Operations | -1,495.53%-51.16M | -24.91%-305.6K | -72.55%-3.21M | ---244.67K | ---1.86M |
| Minority interest income | |||||
| Net income attributable to the parent company | -1,495.53%-51.16M | -28.35%-314.03K | -72.55%-3.21M | -244.67K | -1.86M |
| Preferred stock dividends | |||||
| Other preferred stock dividends | |||||
| Net income attributable to common stockholders | -1,495.53%-51.16M | -28.35%-314.03K | -72.55%-3.21M | -244.67K | -1.86M |
| Basic earnings per share | -3,008.39%-7.82 | -28.35%-0.0246 | -72.55%-0.2516 | -0.0192 | -0.1458 |
| Diluted earnings per share | -3,008.39%-7.82 | -28.35%-0.0246 | -72.55%-0.2516 | -0.0192 | -0.1458 |
| Dividend per share | |||||
| Currency Unit | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg